Brenda Thompson: Daily

A UK-developed LiDAR sensor will give Europe's Argonaut lander the 'eyes' it needs for a safe, autonomous touchdown, marking a new era of lunar exploration.

As its lead therapy for NCFB enters clinical trials, Revagenix promotes a seasoned drug developer to steer its patient-centric strategy in the chronic disease market.

The connectivity firm is betting its future on a massive expansion into defense, energy, and critical minerals. Can its M&A-fueled strategy secure America?

With healthcare costs set to jump 9%, a new partnership offers a transparent, integrated plan to give employers and their workers a more sustainable path.

Philippine giant SM Group's 24 governance awards are more than accolades; they reveal a strategic playbook for creating lasting value amid global uncertainty.

A new state-funded program in Volusia County targets the 18-24 age group, aiming to bridge a critical gap in care and build resilient futures.

Global Industrial's partnership with Harmony Heights does more than create outdoor spaces; it rebuilds a community and pioneers a new model for corporate value.

IntelliGenome's revolutionary CRISPR-TB diagnostic arrives in South Africa via a key partnership, offering a new, blood-based tool to tackle the TB crisis.

How a partnership between pet brand VETRESKA and F1 star Ollie Bearman is redefining pet ownership for a generation that lives life in the fast lane.

A new partnership between Cartera and Kigo aims to reshape retail rewards for over 100 million members by merging a massive offer catalog with AI.

Graphite One's Ohio facility clears a key regulatory hurdle, accelerating a plan to build the first fully integrated US graphite supply chain.

A $50,000 donation is just the start. Discover how Earth's Best is tackling a systemic crisis, empowering consumers to help NYC's 154,000 homeless students.

A new partnership between Nouveau Biosciences and Anova aims to fast-track a novel nanomedicine, offering a beacon of hope for patients with aggressive lymphomas.

One nonprofit is attempting a world record with a 25-hour training marathon. The real prize? Creating a permanent, free library of digital skills for all.

George Kailas leverages a retail-tested signal library and a 'Flash Boys' alum to launch Aethon, a hedge fund aiming to demystify AI trading.

As federal mandates push to end decades of stagnation, one company's 'truly real-time' platform offers a foundational fix for drug development.

A U.S.-China partnership is testing a drug that could replace cataract surgery. The ZOC2017217 eye drop aims to reverse vision loss for millions.

Dr. Sydney C. Butts, a leading facial plastic surgeon, joins ENT & Allergy Associates, bringing world-class reconstructive and aesthetic care to Brooklyn.

NUBURU is launching a bold, premium-priced $38M offering to acquire Tekne, clear its books, and secure its NYSE listing in a high-stakes pivot to defense.

As Kayne Anderson BDC prepares its Q2 report, investors are watching for clues on credit quality and the resilience of its senior-secured loan strategy.